课题基金 / 基金详情

Pannexin 1 in Rhabdomyosarcoma: Role in Pathogenesis and Progression & Mechanisms of Action.

Pannexin 1 in Rhabdomyosarcoma: Role in Pathogenesis and Progression & Mechanisms of Action.
Pannexin 1 在横纹肌肉瘤中的作用：在发病机制和进展中的作用
批准号：
468011
负责人：
Cowan Kyle
金额：
$4.37万
依托单位：
Children's Hospital of Eastern Ontario Research Institute Inc
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-02-01 至 2024-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=468011&lang=en
关键词：
Childhood And Young Adult Oncogenes And Tumour Suppressors Sarcoma Tumour Progression And Metastasis

项目摘要

项目成果

Cowan Kyle的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Rhabdomyosarcoma (RMS) is the most common soft tissue cancer in Canadian children. RMS is a skeletal muscle-derived soft-tissue sarcoma affecting children and adolescents. Management of RMS is challenging and the cure rate for metastatic RMS remains below
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of Pannexin 1 in Skeletal Muscle Regeneration and Duchenne Muscular Dystrophy
The role of Pannexin 1 in Skeletal Muscle Regeneration and Duchenne Muscular Dystrophy